News
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
The Centers for Disease Control and Prevention (CDC) yesterday declared its investigation into a multistate Salmonella ...
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results